CL2008001269A1 - Uso de un inhibidor de desacetilasa de histona par el tratamiento de canceres gastro intestinales - Google Patents

Uso de un inhibidor de desacetilasa de histona par el tratamiento de canceres gastro intestinales

Info

Publication number
CL2008001269A1
CL2008001269A1 CL2008001269A CL2008001269A CL2008001269A1 CL 2008001269 A1 CL2008001269 A1 CL 2008001269A1 CL 2008001269 A CL2008001269 A CL 2008001269A CL 2008001269 A CL2008001269 A CL 2008001269A CL 2008001269 A1 CL2008001269 A1 CL 2008001269A1
Authority
CL
Chile
Prior art keywords
treatment
histone deacetylase
deacetylase inhibitor
gastro intestinal
intestinal cancers
Prior art date
Application number
CL2008001269A
Other languages
English (en)
Inventor
Peter Wisdom Atadja
Original Assignee
Novartis Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=39683987&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=CL2008001269(A1) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Novartis Ag filed Critical Novartis Ag
Publication of CL2008001269A1 publication Critical patent/CL2008001269A1/es

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/40—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil
    • A61K31/403—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil condensed with carbocyclic rings, e.g. carbazole
    • A61K31/404—Indoles, e.g. pindolol
    • A61K31/4045—Indole-alkylamines; Amides thereof, e.g. serotonin, melatonin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical & Material Sciences (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Organic Chemistry (AREA)
  • Epidemiology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Indole Compounds (AREA)

Abstract

Uso de un inhibidor de desacetilasa de histona par el tratamiento de cáncer gastrointestinal.
CL2008001269A 2007-05-04 2008-05-02 Uso de un inhibidor de desacetilasa de histona par el tratamiento de canceres gastro intestinales CL2008001269A1 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US91599607P 2007-05-04 2007-05-04

Publications (1)

Publication Number Publication Date
CL2008001269A1 true CL2008001269A1 (es) 2008-12-19

Family

ID=39683987

Family Applications (1)

Application Number Title Priority Date Filing Date
CL2008001269A CL2008001269A1 (es) 2007-05-04 2008-05-02 Uso de un inhibidor de desacetilasa de histona par el tratamiento de canceres gastro intestinales

Country Status (16)

Country Link
EP (1) EP2142190A1 (es)
JP (1) JP2010526149A (es)
KR (1) KR20100016171A (es)
CN (1) CN101674825A (es)
AU (1) AU2008247603A1 (es)
BR (1) BRPI0811112A2 (es)
CA (1) CA2683554A1 (es)
CL (1) CL2008001269A1 (es)
IL (1) IL201318A0 (es)
MA (1) MA31356B1 (es)
MX (1) MX2009011692A (es)
RU (1) RU2009144842A (es)
TN (1) TN2009000427A1 (es)
TW (1) TW200908964A (es)
WO (1) WO2008137630A1 (es)
ZA (1) ZA200906739B (es)

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
PE20020354A1 (es) * 2000-09-01 2002-06-12 Novartis Ag Compuestos de hidroxamato como inhibidores de histona-desacetilasa (hda)
EP1682538A4 (en) * 2003-10-27 2009-05-27 S Bio Pte Ltd BIARYL-ASSOCIATED HYDROXAMATE: PREPARATION AND PHARMACEUTICAL APPLICATIONS
AR046920A1 (es) * 2003-10-27 2006-01-04 S Bio Pte Ltd Hidroxamatos conectados a acilurea y conectado a sulfonilurea
WO2006075165A1 (en) * 2005-01-13 2006-07-20 Btg International Limited Combination of oncolytic viruses with angiogenesis inhibitors

Also Published As

Publication number Publication date
WO2008137630A1 (en) 2008-11-13
JP2010526149A (ja) 2010-07-29
TW200908964A (en) 2009-03-01
CN101674825A (zh) 2010-03-17
MX2009011692A (es) 2009-11-10
TN2009000427A1 (en) 2011-03-31
ZA200906739B (en) 2010-06-30
AU2008247603A1 (en) 2008-11-13
KR20100016171A (ko) 2010-02-12
MA31356B1 (fr) 2010-05-03
RU2009144842A (ru) 2011-06-10
CA2683554A1 (en) 2008-11-13
IL201318A0 (en) 2010-05-31
EP2142190A1 (en) 2010-01-13
BRPI0811112A2 (pt) 2014-12-23

Similar Documents

Publication Publication Date Title
CL2008000822A1 (es) Metodo para el tratamiento de la obesidad usando un inhibidor sglt2.
CL2009000545A1 (es) Uso de un antagonista de c-met y un antagonista de her para el tratamiento de cancer.
CL2015002591A1 (es) Entidades químicas.
CL2012003415A1 (es) Compuestos derivados de 2-oxo-piperidina y 1,1-dioxido-tiazina, inhibidores de mdm2; composicion farmaceutica que los comprende; y su uso para el tratamiento del cancer .
CL2011003229A1 (es) Compuestos conjugados derivados de criptoficina; procedimiento de preparacion; y su uso para el tratamiento del cancer.
MX2015007205A (es) Inhibidores de la desmetilasa de histona.
CL2012001627A1 (es) Compuestos derivados de 1,3-tiazol-fenilaminopirimidinas, inhibidores de syk; composición farmacéutica; y su uso para el tratamiento de la artritis reumatoide y cancer.
CL2010000320A1 (es) Un compuesto 8-(1,3-dihidro-isoindol-2-ilmetil)-2,9-dihidro-1,2,7,9-tetraaza-fenalen-3-ona, como inhibidor de parp; composicion farmaceutica; y su uso para el tratamiento del cancer.
BRPI0818320A2 (pt) composição para tratamento de câncer de próstata (pca)
TW200738725A (en) Unsaturated mTOR inhibitors
EA201270619A1 (ru) Применение бетанехола для лечения ксеростомии
BRPI0817860A2 (pt) inibidores de histona deacetilase
CL2008002369A1 (es) Compuestos derivados de piridin-3-il-oxipiridin-2-il-amino, inhibidores de alk5; composicion farmaceutica que comprende a dicho compuesto; y uso del compuesto en el tratamiento del cancer.
AR066564A1 (es) Una combinacion farmaceutica sinergica para el tratamiento de cancer
DOP2012000006A (es) Agonista de gpr119
EA200971068A1 (ru) Триазолиламинопиримидиновые соединения
CR9301S (es) Cuerpo de grifo
EP2099443A4 (en) ASSOCIATION OF ERA + LIGANDS AND HISTONE DEACETYLASE INHIBITORS IN THE TREATMENT OF CANCER
BRPI0821248A2 (pt) Inibidores de cinesina como fármacos terapêuticos para câncer
ATE458487T1 (de) Tumorbehandlung mit gliotoxin-derivaten
EA200870148A1 (ru) Производные сулиндака, их применение и получение
EA201170821A1 (ru) Энзастаурин для лечения рака
CL2008001728A1 (es) Compuestos derivados de indolinonas; composicion farmaceutica que comprende a dicho compuesto; y uso del compuesto para el tratamiento de cancer, infecciones, enfermedades inflamatorias y autoinmunes.
BR112012011823A2 (pt) métodos e composições para tratar tumores sólidos e outras malignidades
EA201390499A1 (ru) Соединения, подходящие для ингибирования снк1